Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; …
Full ZJYL analysis →
Competitive advantage assessment
Key strengths
Above-Peer Asset ProductivityAsset productivity is strong vs peers (score 0.66). Above-peer ROA underpins the growth durability narrative.
Key risks
Below-Peer Gross MarginsGross margin quality lags peers (score 0.19). May indicate commodity-like product mix or distributor margin drag.
Where ZJYL ranks in Medical Instruments & Supplies
JIN MEDICAL INTERNATIONAL LTD. ranks #41 of 62
scored companies in Medical Instruments & Supplies by moat score — the top 66%.
The widest moat in the group is Intuitive Surgical, Inc. (ISRG)
at 86/100.
Moat scores for companies ranked near ZJYL in Medical Instruments & Supplies
How ZJYL scores on the Medical Devices & Diagnostics defenses
Pricing Power & Consumable Moat
Score 26
· 25% of the moat score
In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.
R&D Pipeline & Capital Returns
Score 60
· 20% of the moat score
Research spending is how a device company keeps its installed base current, but spending alone proves nothing.
FCF Quality & Cash Conversion
Score 30
· 20% of the moat score
MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.
Commercial Execution
Score 43
· 15% of the moat score
Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.
Capital Structure & Resilience
Score 13
· 12% of the moat score
Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.
Growth Durability
Score 56
· 8% of the moat score
Growth durability separates an expanding installed base from a good product cycle.
What is JIN MEDICAL INTERNATIONAL LTD.'s moat score?
JIN MEDICAL INTERNATIONAL LTD. (ZJYL) scores 38 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #41 of 62 scored companies in Medical Instruments & Supplies, the top 66%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 61 companies in Medical Instruments & Supplies. Its strongest defense is R&D Pipeline & Capital Returns (60/100) and its weakest is Capital Structure & Resilience (13/100).
How does JIN MEDICAL INTERNATIONAL LTD. compare with other Medical Instruments & Supplies companies?
JIN MEDICAL INTERNATIONAL LTD. ranks #41 of 62 scored companies in Medical Instruments & Supplies by moat score. The widest moat in Medical Instruments & Supplies is Intuitive Surgical, Inc. (ISRG) at 86/100. The companies ranked closest are Microbot Medical Inc. (MBOT) at 39 just above it and NexGel, Inc (NXGL) at 38 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 61 companies in Medical Instruments & Supplies. The defenses are then weighted to produce the overall score out of 100.
Why is JIN MEDICAL INTERNATIONAL LTD. scored with the Medical Devices & Diagnostics template?
Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.
Which competitive defenses are measured for JIN MEDICAL INTERNATIONAL LTD.?
The Medical Devices & Diagnostics template measures 6 defenses, and ZJYL scores: Pricing Power & Consumable Moat (26), R&D Pipeline & Capital Returns (60), FCF Quality & Cash Conversion (30), Commercial Execution (43), Capital Structure & Resilience (13), Growth Durability (56). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.